Peripheral Vascular Devices Market Size, Share & Trends Analysis | United States | 2023-2029 | MedSuite | Includes: Peripheral Vascular Stents, PTA Balloon Catheters, and 17 more

  • Year: 2023
  • Scope: 10 Years
  • Region: United States
  • Pages: 756
  • Published Date: 2023-02-14
  • Type: MedSuite

Product Description

Overall, the U.S. peripheral vascular device market was valued at $8 billion in 2022. This is expected to increase over the forecast period at a CAGR of 4.4% to reach $10.9 billion.

The full report suite on the U.S. market for peripheral vascular devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management devices, inferior vena cava filters (IVCFs) and retrieval devices, carotid shunts, transcarotid arterial revascularization (TCAR) flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral IVUS catheters.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Peripheral Vascular Procedure Volumes
  • Market Forecasts Until 2029, and Historical Data to 2019
  • Market Drivers & Limiters for Each Peripheral Vascular Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

U.S. PERIPHERAL VASCULAR DEVICE PROCEDURE NUMBERS

Peripheral vascular procedures include plain-old balloon angioplasty (POBA), stenting, drug-coated balloon (DCB), atherectomy, intravascular lithotripsy, CTO crossing, surgical graft, stent graft, embolic protection, peripheral thrombus management, inferior vena cava filter placement, carotid intervention, vascular closure, transcatheter embolization and peripheral IVUS procedures. Many peripheral vascular procedures are performed using a vascular closure device. Intravascular lithotripsy and embolic protection devices are used in a small sub-set of peripheral vascular procedures.

U.S. PERIPHERAL VASCULAR DEVICE MARKET TRENDS

U.S. Peripheral Vascular Device MarketOne of the greatest limitations in this market is the pricing pressure that is occurring within the office-based lab (OBL) setting. Although these clinics have led to a significant increase in efficiency, reducing the average time for patients to be within a hospital, these settings are also incredibly price sensitive. It is typical that there is a 30% discount on devices sold to an OBL, relative to a hospital. As more OBLs continue to be developed, and more procedures continue to be shifted towards this setting, pricing pressure is expected on PTA balloons, stents, atherectomy devices and associated products for performing routine procedures.

U.S. PERIPHERAL VASCULAR DEVICE MARKET SHARE INSIGHTS

Within the U.S. vascular access market there are 3 top market share competitors – Medtronic, W.L. Gore, and Boston Scientific.Medtronic was the leading competitor in the total peripheral vascular devices market in 2022. The company derives the majority of its revenue from its strong showing in the high value stent graft, DCB and atherectomy market segments. Medtronic led the U.S. DCB market in 2022. The addition of a DCB to Medtronic’s portfolio has buoyed the company’s share of adjacent market segments, including bare-metal stents, standard PTA balloons and more. The company’s broad market share has also afforded it tremendous competitive success within the OBL setting. Medtronic’s atherectomy portfolio especially has generated significant growth for the company within this setting, and is the second-largest revenue generator, overtaking the stent market.

Detailed Market Segmentation

  • Peripheral Vascular Stent Market MedCore – Includes:
    • Arterial and Venous PV Stents.
  • PTA Balloon Catheter Market – MedCore – Includes:
    • Standard, high-pressure, large, small and specialty PTA balloons.
  • Drug-Coated Balloon Market – MedCore – Includes:
    • SFA drug-coated balloons, BTK drug-coated balloons, and AV access drug-coated balloons.
  • Atherectomy Device Market – MedCore – Includes:
    • Laser atherectomy devices and mechanical atherectomy disposables.
  • Intravascular Lithotripsy Market – MedCore – Includes:
    • Hospital intravascular lithotripsy and office-based lab intravascular lithotripsy market segments.
  • Chronic Total Occlusion (CTO) Device Market – MedCore – Includes:
    • Re-canalization and re-entry devices
  • Surgical Graft Market – MedCore – Includes:
    • Lower limb surigcal grafts, aorta repair surgical grafts, and extra-anatomical bypass surgical grafts.
  • Stent Graft Market – MedCore – Includes:
    • abdominal aortic aneurysm (AAA) stent graft segment, the fenestrated (FAA) stent graft segment and the thoracic aortic aneurysm (TAA) stent graft segment
  • Embolic Protection Device Market – MedCore – Includes:
    • EPDs used in procedures performed in the carotid arteries as well as EPDs used in alternative procedures.
  • Peripheral Thrombus Management Device Market – MedCore – Includes:
    • Traditional thrombectomy market, pharmaco-mechanical thrombectomy market, and the catheter directed thrombolysis market.
  • Inferior Vena Cava Filter & Retrieval Device Market – MedCore – Includes:
    • Retrievable IVCF segment, the permanent IVCF segment and the IVCF retrieval device segments.
  • Carotid Shunt Market – MedCore – A carotid shunt is a piece of medical tubing used by some physicians in carotid endarterectomy procedures.
  • Transcarotid Artery Revascularization MarketMedCore – Includes:
    • TCAR neuroprotection system and the TCAR bare-metal stent.
  • Diagnostic & Interventional Catheter Market – MedCore – Includes:
      • Diagnostic catheter segment and the support catheter segment.
  • Diagnostic & Interventional Guidewire Market – MedCore – Includes:
    • Standard Guidewires and Hydrophilic Guidewires.
  • Introducer Sheath Market – MedCore – Includes:
    • Both standard and guiding introducer sheaths.
  • Vascular Closure Device Market – MedCore – Includes:
    • Non-invasive vascular closure devices and invasive vascular closure devices.
  • Transcatheter Embolization Device Market – MedCore – Includes:
    • Embolization particle, the embolization coil, the embolization liquid and the embolization (vascular) plug segments.
  • Peripheral IVUS Catheter Market – MedCore  – An IVUS system consists of two components: the disposable IVUS catheter and the IVUS consoles.

RESEARCH SCOPE SUMMARY

Report Attribute Details
Region North America (United States)
Base Year  2022
Forecast  2023-2029
Historical Data  2019-2022
Quantitative Coverage Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

\WHY CHOOSE IDATA?

  • Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
  • Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
  • Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
  • Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

 

FREE Sample Report

Table of Contents

TABLE of CONTENTS
List of Figures
List of Charts
executive summary
U.S. Peripheral Vascular Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Included
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
research methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
impact of covid-19 on THE U.S. Peripheral Vascular Device Market
2.1 Introduction
2.2 Analysis By Market Segment
2.2.1 Worst Case Scenario
2.2.2 Base Case Scenario
2.2.3 Best Case Scenario
Disease Overview
3.1 Basic Anatomy
3.2 Disease Treatments & Diagnostics
3.2.1 Aortic Aneurysms
3.2.2 Atherosclerosis
3.2.3 Peripheral Arterial Disease (PAD)
3.2.4 Deep Vein Thrombosis
3.2.5 Pulmonary Embolism
3.3 Patient Demographics
3.3.1 Aortic Aneurysms
3.3.2 Atherosclerosis
3.3.3 Peripheral Arterial Disease (PAD)
3.3.4 Deep Vein Thrombosis
3.3.5 Pulmonary Embolism
Product Assessment
4.1 Introduction
4.2 Product Portfolios
4.2.1 Peripheral Vascular Stent
4.2.2 PTA Balloon Catheter
4.2.3 Drug-Coated Balloon
4.2.4 Atherectomy Device
4.2.5 Intravascular Lithotripsy Market
4.2.6 Chronic Total Occlusion
4.2.7 Surgical Graft
4.2.8 Stent Graft
4.2.9 Embolic Protection
4.2.10 Peripheral Thrombus Management
4.2.11 Inferior Vena Cava Filter and Retrieval
4.2.12 Carotid Shunt
4.2.13 Transcarotid Artery Revascularization
4.2.14 Diagnostic & Interventional Catheter
4.2.15 Diagnostic and Interventional Guidewire
4.2.16 Introducer Sheath
4.2.17 Vascular Closure Device
4.2.18 Transcatheter Embolization Device
4.2.19 Peripheral IVUS Catheter
4.3 Regulatory Issues and Recalls
4.3.1 Peripheral Vascular Stent
4.3.1.1 Becton Dickinson
4.3.1.2 Boston Scientific
4.3.1.3 Cardinal Health
4.3.1.4 Cook Medical
4.3.1.5 Maquet
4.3.1.6 Medtronic
4.3.1.7 Silk Road Medical
4.3.1.8 W.L. Gore
4.3.2 PTA Balloon Catheter
4.3.2.1 Becton Dickinson
4.3.2.2 Cardinal Health
4.3.2.3 Cook Medical
4.3.2.4 Medtronic
4.3.3 Atherectomy Device
4.3.3.1 Boston Scientific
4.3.3.2 Cardiovascular Systems Inc.
4.3.3.3 Medtronic
4.3.4 Intravascular Lithotripsy Market
4.3.4.1 Shockwave Medical
4.3.5 Introducer Sheaths
4.3.6 Peripheral Thrombus Management Devices
4.3.7 Chronic Total Occlusion
4.3.7.1 Edwards Lifesciences
4.3.8 Surgical Graft
4.3.8.1 Maquet
4.3.8.2 Terumo
4.3.8.3 W.L. Gore
4.3.9 Stent Graft
4.3.9.1 Endologix
4.3.9.2 Cook Medical
4.3.9.3 Medtronic
4.3.10 Peripheral Thrombus Management
4.3.10.1 Boston Scientific
4.3.10.2 Teleflex
4.3.11 Inferior Vena Cava Filter & Retrieval
4.3.11.1 Cook Medical
4.3.12 Transcarotid Artery Revascularization
4.3.12.1 Silk Road Medical
4.3.13 Diagnostic & Interventional Catheter
4.3.13.1 AngioDynamics
4.3.13.2 Becton Dickinson
4.3.13.3 Boston Scientific
4.3.13.4 Cardinal Health
4.3.13.5 Cook Medical
4.3.14 Diagnostic & Interventional Guidewire
4.3.14.1 Cook Medical
4.3.15 Introducer Sheath
4.3.15.1 Abbott
4.3.15.2 Cardinal Health
4.3.15.3 Cook Medical
4.3.16 Transcatheter Embolization Device
4.3.16.1 Cook Medical
4.3.16.2 Terumo
4.3.17 Peripheral IVUS Catheter
4.3.17.1 Boston Scientific
4.4 Clinical Trials
4.4.1 Peripheral Vascular Stent
4.4.2 PTA Balloon Catheter
4.4.3 Drug-Coated Balloon
4.4.4 Atherectomy Device
4.4.5 Intravascular Lithotripsy
4.4.6 Surgical Graft
4.4.7 Stent Graft
4.4.8 Embolic Protection
4.4.9 Peripheral Thrombus Management
4.4.10 Inferior Vena Cava Filter & Retrieval
4.4.11 Transcarotid Artery Revascularization
4.4.12 Vascular Closure Device
4.4.13 Transcatheter Embolization Device
U.S. Peripheral Vascular Device Market Overview
5.1 Introduction
5.1.1 Atherosclerosis
5.1.2 Peripheral Arterial Disease (PAD)
5.2 Market Overview & Trend Analysis
5.3 Drivers and Limiters
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 Competitive Market Share Analysis
5.5 Mergers and Acquisitions
5.6 Company Profiles
5.6.1 Abbott
5.6.2 Becton Dickinson
5.6.3 Boston Scientific
5.6.4 Cardinal Health
5.6.5 Cardiovascular Systems, Inc.
5.6.6 Cook Medical
5.6.7 Medtronic
5.6.8 Penumbra
5.6.9 Philips
5.6.10 Shockwave Medical
5.6.11 Silk Road Medical
5.6.12 Terumo
5.6.13 W.L. Gore
5.7 SWOT Analysis
5.7.1 Abbott
5.7.2 Becton Dickinson
5.7.3 Boston Scientific
5.7.4 Cardinal Health
5.7.5 Cardiovascular Systems, Inc.
5.7.6 Cook Medical
5.7.7 Medtronic
5.7.8 Penumbra
5.7.9 Philips
5.7.10 Shockwave Medical
5.7.11 Silk Road Medical
5.7.12 Terumo
5.7.13 W.L. Gore
Procedure Numbers
6.1 Introduction
6.2 Procedures
6.2.1 Total Peripheral Vascular Procedures
6.2.2 Total Peripheral Vascular Procedures by Device Type, Indication, Intervention & Care Setting
6.2.2.1 Above-the-Knee Procedures
6.2.2.1.1 Above-the-Knee Stent Procedures
6.2.2.1.2 Above-the-Knee POBA Procedures by Care Setting
6.2.2.1.3 Above-the-Knee DCB Procedures by Care Setting
6.2.2.1.4 Intravascular Lithotripsy Procedures
6.2.2.1.5 Above-the-Knee Atherectomy without Stent Procedures by Care Setting
6.2.2.1.6 Above-the-Knee Atherectomy with Stent Procedures by Care Setting
6.2.2.1.7 Surgical Graft Procedures
6.2.2.2 Below-the-Knee Procedures
6.2.2.2.1 Below-the-Knee Stent Procedures
6.2.2.2.2 Below-the-Knee POBA Procedures by Care Setting
6.2.2.2.3 Below-the-Knee DCB Procedures by Care Setting
6.2.2.2.4 Intravascular Lithotripsy Procedures
6.2.2.2.5 Below-the-Knee Atherectomy without Stent Procedures by Care Setting
6.2.2.2.6 Below-the-Knee Atherectomy with Stent Procedures by Care Setting
6.2.2.2.7 Surgical Graft Procedures
6.2.2.3 Iliac Procedures
6.2.2.3.1 Iliac Stent Procedures
6.2.2.3.2 Iliac POBA Procedures by Care Setting
6.2.2.4 AV Access Procedures
6.2.2.4.1 AV Access Covered Stent Procedures by Care Setting
6.2.2.4.2 AV Access POBA Procedures by Care Setting
6.2.2.4.3 AV Access DCB Procedures by Care Setting
6.2.2.5 Renal Procedures
6.2.2.6 Carotid Procedures
6.2.3 Peripheral Vascular Stent Procedures
6.2.3.1 Peripheral Arterial Stent Procedures
6.2.3.1.1 Bare-Metal Stent Procedures
6.2.3.1.2 Covered Stent Procedures
6.2.3.1.3 Drug-Eluting Stent Procedures
6.2.3.2 Peripheral Venous Stent Procedures
6.2.4 PTA Balloon Catheter Procedures
6.2.5 Drug-Coated Balloon Procedures
6.2.5.1 Drug-Coated Balloon Procedures by Care Setting
6.2.5.2 Drug-Coated Balloon Procedures by Indication
6.2.6 Atherectomy Procedures
6.2.6.1 Atherectomy Procedures by Device Type
6.2.6.2 Atherectomy Procedures by Indication
6.2.6.2.1 Fem-Popliteal Artery Atherectomy Procedures by Type
6.2.6.2.2 Infra-Popliteal Artery Atherectomy Procedures by Type
6.2.6.3 Atherectomy Procedures by Care Setting
6.2.7 Intravascular Lithotripsy Procedures
6.2.7.1.1 Intravascular Lithotripsy Procedures by Indication
6.2.8 CTO Device Procedures
6.2.8.1 CTO Device Procedures by Type
6.2.9 Surgical Graft Procedures
6.2.9.1 Surgical Graft Procedures by Graft Material
6.2.9.2 Surgical Graft Procedures by Indication
6.2.9.2.1 Lower Limb Surgical Graft Procedures by Anatomy
6.2.9.2.2 Aorta Repair Surgical Graft Procedures by Anatomy
6.2.10 Stent Graft Procedures
6.2.10.1 Endovascular Stent Graft Procedures by Type
6.2.10.2 EVAR Procedures
6.2.10.2.1 EVAR Procedures by Anatomy
6.2.10.2.2 EVAR Procedures by Device Type
6.2.10.2.3 EVAR Procedures by Complexity
6.2.10.2.4 EVAR Procedures by Fenestration
6.2.10.2.5 EVAR Procedures by Anesthesia Type
6.2.10.2.6 EVAR Procedures by Gender
6.2.10.3 TEVAR Procedures
6.2.10.3.1 TEVAR Procedures by Indication
6.2.10.3.2 TEVAR Procedures by Anesthesia Type
6.2.10.3.3 TEVAR Procedures by Gender
6.2.11 Embolic Protection Procedures
6.2.11.1 Embolic Protection Procedures by Type
6.2.12 Peripheral Thrombus Management Procedures
6.2.12.1 Peripheral Thrombus Management Procedures by Procedure Type
6.2.12.2 Peripheral Thrombus Management Procedures by Indication
6.2.13 Inferior Vena Cava Filter Procedures
6.2.13.1 Inferior Vena Cava Filter Procedures by Procedure Type
6.2.13.1.1 IVCF Placement Procedures by Device Type
6.2.14 Carotid Intervention Procedures
6.2.14.1 Carotid Intervention Procedures by Procedure Type
6.2.15 Vascular Closure Device Procedures
6.2.15.1 Vascular Closure Device Procedures by Device Type
6.2.15.1.1 Invasive Vascular Closure Procedures by Device Size
6.2.15.2 Vascular Closure Procedures by Approach
6.2.16 Transcatheter Embolization Procedures
6.2.16.1 Transcatheter Embolization Procedures by Device Type
6.2.16.1.1 Transcatheter Particle Embolization Procedures by Device Type
6.2.16.1.2 Transcatheter Coil Embolization Procedures by Device Type
6.2.17 Peripheral IVUS Procedures
6.2.17.1 Peripheral IVUS Procedures by Indication
6.2.17.2 Peripheral IVUS Procedures by Care Setting
Peripheral Vascular Stent Market
7.1 Introduction
7.1.1 Peripheral Arterial Stents
7.1.1.1 Off-Label Use
7.1.1.2 Covered Stents
7.1.1.3 Drug-Eluting Stents
7.1.1.4 Infrapopliteal Stenting
7.1.1.5 Stent Length
7.1.1.6 General Information
7.1.2 Venous Stents
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Peripheral Arterial Stent Market
7.3.1.1 Total Bare-Metal Peripheral Arterial Stent Market
7.3.1.1.1 Bare-Metal Peripheral Arterial Stent Market by Indication
7.3.1.1.2 Bare-Metal Carotid Stent Market
7.3.1.1.3 Bare-Metal Iliac Stent Market
7.3.1.1.4 Bare-Metal Renal Stent Market
7.3.1.1.5 Bare-Metal Fem-Popliteal Stent Market
7.3.1.1.6 Bare-Metal Infra-Popliteal Stent Market
7.3.1.1.7 Bare-Metal Stent Market by Delivery Platform
7.3.1.1.8 Self-Expanding Bare-Metal Stent Market
7.3.1.1.9 Balloon Expanding Bare-Metal Stent Market
7.3.1.2 Total Covered Stent Market
7.3.1.2.1 Iliac Covered Stent Market
7.3.1.2.2 Fem-Popliteal Covered Stent Market
7.3.1.2.3 AV Access Covered Stent Market
7.3.1.3 Total Drug-Eluting Stent Market
7.3.1.3.1 SFA Drug-Eluting Stent Market
7.3.1.3.2 Infra-Popliteal Drug-Eluting Stent Market
7.3.2 Venous Stent Market
7.4 Unit Analysis
7.4.1 Units Sold by Stent Length
7.4.1.1 Bare-Metal Carotid Stent Units
7.4.1.2 Bare-Metal Renal Stent Units
7.4.1.3 Bare-Metal Iliac Stent Units
7.4.1.4 Bare-Metal Fem-Popliteal Stent Units
7.5 Drivers and Limiters
7.5.1 Market Drivers
7.5.2 Market Limiters
7.6 Competitive Market Share Analysis
PTA Balloon Catheter Market
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Total PTA Balloon Catheter Market
8.3.2 Total Standard PTA Balloon Catheter Market
8.3.2.1 Hospital Standard PTA Balloon Catheter Market
8.3.2.2 Office-Based Lab Standard PTA Balloon Catheter Market
8.3.3 Total High-Pressure PTA Balloon Catheter Market
8.3.3.1 Hospital High-Pressure PTA Balloon Catheter Market
8.3.3.2 Office-Based Lab High-Pressure PTA Balloon Catheter Market
8.3.4 Total Large PTA Balloon Catheter Market
8.3.4.1 Hospital Large PTA Balloon Catheter Market
8.3.4.2 Office-Based Lab Large PTA Balloon Catheter Market
8.3.5 Total Small PTA Balloon Catheter Market
8.3.5.1 Small PTA Balloon Catheter Market by Balloon Size
8.3.5.1.1 0.014” Small PTA Balloon Catheter Market
8.3.5.1.2 0.018” Small PTA Balloon Catheter Market
8.3.5.2 Small PTA Balloon Catheter Market by Care Setting
8.3.5.2.1 Hospital Small PTA Balloon Catheter Market
8.3.5.2.2 Office-Based Lab Small PTA Balloon Catheter Market
8.3.6 Total Specialty PTA Balloon Catheter Market
8.3.6.1 Hospital Specialty PTA Balloon Catheter Market
8.3.6.2 Office-Based Lab Specialty PTA Balloon Catheter Market
8.4 Unit Analysis
8.4.1 Units Sold by Application
8.5 Drivers and Limiters
8.5.1 Market Drivers
8.5.2 Market Limiters
8.6 Competitive Market Share Analysis
8.6.1 Standard PTA Balloon Catheter Market
8.6.2 High-Pressure PTA Balloon Catheter Market
8.6.3 Large PTA Balloon Catheter Market
8.6.4 Small PTA Balloon Catheter Market
8.6.5 Specialty PTA Balloon Catheter Market
Drug-Coated Balloon Market
9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Total Drug-Coated Balloon Market
9.3.1.1 SFA Drug-Coated Balloon Market
9.3.1.2 BTK DCB Market
9.3.1.3 AV Access DCB Market
9.4 Unit Analysis
9.4.1 Units Sold by Care Setting
9.5 Drivers and Limiters
9.5.1 Market Drivers
9.5.2 Market Limiters
9.6 Competitive Market Share Analysis
9.6.1 Emerging Competitors
Atherectomy Device Market
10.1 Introduction
10.2 Market Overview
10.3 Market Analysis and Forecast
10.3.1 Atherectomy Device Market by Technology
10.3.1.1 Total Laser Atherectomy Device Market
10.3.1.1.1 Laser Atherectomy Disposable Market
10.3.1.1.2 Laser Atherectomy Console Market
10.3.1.2 Mechanical Atherectomy Disposable Market
10.3.2 Atherectomy Disposable Market by Care Setting
10.3.2.1 Hospital Atherectomy Disposable Market
10.3.2.2 Office-Based Lab Atherectomy Disposable Market
10.4 Drivers and Limiters
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 Competitive Market Share Analysis
Intravascular Lithotripsy Market
11.1 Introduction
11.2 Market Analysis and Forecast
11.2.1 Intravascular Lithotripsy Market by Care Setting
11.2.1.1 Hospital Intravascular Lithotripsy Market
11.2.1.2 Office-Based Lab Intravascular Lithotripsy Market
11.3 Drivers and Limiters
11.3.1 Market Drivers
11.3.2 Market Limiters
11.4 Competitive Market Share Analysis
CTO Device Market
12.1 Introduction
12.2 Market Overview
12.3 Market Analysis and Forecast
12.3.1 Total CTO Device Market
12.3.2 Re-Entry Device Market
12.3.3 Re-Canalization Device Market
12.4 Drivers and Limiters
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 Competitive Market Share Analysis
Surgical Graft Market
13.1 Introduction
13.2 Market Overview
13.2.1 Surgical Graft Market Overview by Indication
13.2.2 Surgical Graft Market Overview by Material
13.3 Market Analysis and Forecast
13.3.1 Total Surgical Graft Market
13.3.2 Surgical Graft Market by Indication
13.3.2.1 Total Lower Limb Surgical Graft Market
13.3.2.1.1 Above-the-Knee Surgical Graft Market
13.3.2.1.2 Below-the-Knee Surgical Graft Market
13.3.2.2 Total Aorta Repair Surgical Graft Market
13.3.2.2.1 Abdominal Aortic Aneurysm Surgical Graft Market
13.3.2.2.2 Thoracic Aortic Aneurysm Surgical Graft Market
13.3.2.3 Extra-Anatomical Bypass Surgical Graft Market
13.3.3 Surgical Graft Market by Material
13.3.3.1 Polyester Surgical Graft Market
13.3.3.2 ePTFE Surgical Graft Market
13.4 Drivers and Limiters
13.4.1 Market Drivers
13.4.2 Market Limiters
13.5 Competitive Market Share Analysis
Stent Graft Market
14.1 Introduction
14.2 Market Overview
14.3 Market Analysis and Forecast
14.3.1 Total Stent Graft Market
14.3.2 Total AAA Stent Graft Market
14.3.2.1 Bifurcated Main Body Graft Market
14.3.2.2 Contralateral/Ipsilateral Iliac Leg/Limb Market
14.3.2.3 Aorto-uni-iliac (AUI) Stent Graft Market
14.3.2.4 Iliac Extension Market
14.3.2.5 Aortic Extension Market
14.3.3 Total FAA Stent Graft Market
14.3.3.1 Fenestrated Distal Bifurcated Graft Market
14.3.3.2 Fenestrated Proximal Body Graft Market
14.3.4 TAA Stent Graft Market
14.4 Drivers and Limiters
14.4.1 Market Drivers
14.4.2 Market Limiters
14.5 Competitive Market Share Analysis
Embolic Protection Device Market
15.1 Introduction
15.1.1 New Applications
15.1.2 Protection Mechanism
15.1.2.1 Filter Devices
15.1.2.2 Balloon Occlusion Systems
15.1.2.3 Flow Redirection
15.2 Market Overview
15.3 Market Analysis and Forecast
15.3.1 Total Embolic Protection Device Market
15.3.2 Carotid EPD Market
15.3.3 Total Alternative EPD Market
15.3.3.1 Renal EPD Market
15.3.3.2 Lower Limb EPD Market
15.4 Drivers and Limiters
15.4.1 Market Drivers
15.4.2 Market Limiters
15.5 Competitive Market Share Analysis
Peripheral Thrombus Management Market
16.1 Introduction
16.1.1 AV Access Thrombectomy Devices
16.1.2 Other Peripheral Applications of Thrombectomy Devices
16.2 Market Overview
16.2.1 Peripheral Thrombus Management Market Overview by Device Type
16.2.2 Peripheral Thrombus Management Market Overview by Indication
16.3 Market Analysis and Forecast
16.3.1 Total Peripheral Thrombus Management Market
16.3.2 Peripheral Thrombus Management Market by Device Type
16.3.2.1 Traditional Thrombectomy Market
16.3.2.2 Pharmacomechanical Thrombectomy Market
16.3.2.3 Catheter Directed Thrombolysis Market
16.3.3 Peripheral Thrombus Management Market by Indication
16.3.3.1 AV Access Thrombectomy Device Market
16.3.3.2 Arterial Thrombectomy Device Market
16.3.3.3 Venous Thrombectomy Device Market
16.4 Drivers and Limiters
16.4.1 Market Drivers
16.4.2 Market Limiters
16.5 Competitive Market Share Analysis
Inferior Vena Cava Filter & RetriEval Device Market
17.1 Introduction
17.2 Market Overview
17.3 Market Analysis and Forecast
17.3.1 Total Inferior Vena Cava Filter & Retrieval Device Market
17.3.1.1 Retrievable IVCF Market
17.3.1.2 Permanent IVCF Market
17.3.2 IVCF Retrieval Device Market
17.4 Drivers and Limiters
17.4.1 Market Drivers
17.4.2 Market Limiters
17.5 Competitive Market Share Analysis
Carotid Shunt Market
18.1 Introduction
18.2 Market Analysis and Forecast
18.3 Drivers and Limiters
18.3.1 Market Drivers
18.3.2 Market Limiters
18.4 Competitive Market Share Analysis
Transcarotid Artery Revascularization Market
19.1 Introduction
19.2 Market Overview
19.3 Market Analysis and Forecast
19.3.1 Transcarotid Bare-Metal Stent Market
19.3.2 TCAR Neuroprotection System Market
19.4 Drivers and Limiters
19.4.1 Market Drivers
19.4.2 Market Limiters
19.5 Competitive Market Share Analysis
Diagnostic & Interventional Catheter Market
20.1 Introduction
20.2 Market Overview
20.3 Market Analysis and Forecast
20.3.1 Total Diagnostic & Interventional Catheter Market
20.3.2 Total Diagnostic Catheter Market
20.3.2.1 Standard Diagnostic Catheter Market
20.3.2.2 Hydrophilic Diagnostic Catheter Market
20.3.3 Support Catheter Market
20.4 Drivers and Limiters
20.4.1 Market Drivers
20.4.2 Market Limiters
20.5 Competitive Market Share Analysis
Diagnostic & Interventional Guidewire Market
21.1 Introduction
21.2 Market Overview
21.3 Market Analysis and Forecast
21.3.1 Total Diagnostic & Interventional Guidewire Market
21.3.2 Standard Guidewire Market
21.3.3 Hydrophilic Guidewire Market
21.4 Drivers and Limiters
21.4.1 Market Drivers
21.4.2 Market Limiters
21.5 Competitive Market Share Analysis
Introducer Sheath Market
22.1 Introduction
22.2 Market Overview
22.3 Market Analysis and Forecast
22.3.1 Total Introducer Sheath Market
22.3.2 Standard Introducer Sheath Market
22.3.3 Guiding Introducer Sheath Market
22.4 Drivers and Limiters
22.4.1 Market Drivers
22.4.2 Market Limiters
22.5 Competitive Market Share Analysis
Vascular Closure Device Market
23.1 Introduction
23.2 Market Overview
23.2.1 Vascular Closure Device Market Overview by Device Type
23.2.2 Vascular Closure Device Market Overview by Approach
23.3 Market Analysis and Forecast
23.3.1 Total Vascular Closure Device Market
23.3.2 Vascular Closure Device Market by Device Type
23.3.2.1 Non-Invasive Vascular Closure Device Market
23.3.2.2 Total Invasive Vascular Closure Device Market
23.3.2.2.1 Small-Bore Invasive VCD Market
23.3.2.2.2 Large-Bore Invasive VCD Market
23.3.3 Vascular Closure Device Market by Approach
23.3.3.1 Radial VCD Market
23.3.3.2 Femoral VCD Market
23.4 Drivers and Limiters
23.4.1 Market Drivers
23.4.2 Market Limiters
23.5 Competitive Market Share Analysis
Transcatheter Embolization Device Market
24.1 Introduction
24.1.1 Particle Embolics
24.1.2 Coil Embolics
24.1.3 Liquid Embolics
24.1.4 Vascular Plugs
24.2 Market Overview
24.3 Market Analysis and Forecast
24.3.1 Total Transcatheter Embolization Device Market
24.3.2 Total Embolization Particle Market
24.3.2.1 PVA Embolization Particle Market
24.3.2.2 Microsphere Embolization Particle Market
24.3.2.3 Drug-Eluting Embolization Particle Market
24.3.2.4 Radioactive Embolization Particle Market
24.3.3 Total Embolization Coil Market
24.3.3.1 Pushable Coil Market
24.3.3.2 Detachable Coil Market
24.3.4 Embolization Liquid Market
24.3.5 Embolization Plug Market
24.4 Drivers and Limiters
24.4.1 Market Drivers
24.4.2 Market Limiters
24.5 Competitive Market Share Analysis
Peripheral IVUS Catheter Market
25.1 Introduction
25.2 Market Analysis and Forecast
25.3 Drivers and Limiters
25.3.1 Market Drivers
25.3.2 Market Limiters
25.4 Competitive Market Share Analysis
Abbreviations

Companies Included:

·         Abbott Vascular ·         Infraredx
·         Acist Medical ·         Integra LifeSciences
·         Advanced Vascular Dynamics ·         LeMaitre Vascular
·         ALN International ·         Lucas Medical
·         AngioDynamics ·         Maquet
·         Argon Medical ·         Marine Polymer Technologies
·         ArtVentive ·         Medline
·         Ashai Intecc USA Inc. ·         Medtronic
·         Avinger ·         Merit Medical
·         B. Braun ·         Mermaid Medical
·         Balt ·         Micro Medical Solutions
·         Baylis Medical ·         Morris Innovative Inc.
·         Becton Dickinson ·         Navilyst Medical
·         Biotronik ·         Nipro
·         Blockade Medical ·         NuCryo Vascular
·         Boston Scientific ·         Okami Medical
·         Cardinal Health ·         Oscor
·         Cardiovascular Systems, Inc. ·         Penumbra
·         Cardiva ·         Pfizer
·         Cerenovus ·         PFM Medical
·         CME ·         Philips
·         Concordance Healthcare ·         Provisio Medical
·         Consolidated Service Center ·         Ra Medical
·         Contego Medical ·         Radius Medical
·         Control Medical Technology ·         Reflow Medical
·         Cook Medical ·         Rex Medical
·         Edwards LifeSciences ·         Roxwood Medical
·         Endologix ·         Shockwave Medical
·         HemCon Medical Technologies ·         Silk Road Medical
·         Inari Medical ·         Sirtex
·         Surmodics ·         TZ Medical
·         Teleflex ·         Varian Medical Systems
·         Terumo ·         Vascular Flow Technologies
·         Thrombolex ·         Veryan Medical
·         Tricol Biomedical ·         W.L. Gore

List of Charts

Chart 1‑1: Peripheral Vascular Device Market by Segment, U.S., 2022 – 2029
Chart 1‑2: Peripheral Vascular Device Market Overview, U.S., 2022 & 2029
Chart 2‑1: Multi-Scenario Peripheral Vascular Device Market Forecast, U.S., 2019 – 2029 (US$M)
Chart 5‑1: Peripheral Vascular Device Market by Segment, U.S., 2019 – 2029
Chart 5‑2: Leading Competitors, Peripheral Vascular Device Market, U.S., 2022
Chart 6‑1: Peripheral Vascular Procedures by Segment, U.S., 2019 – 2029
Chart 7‑1: Peripheral Vascular Stent Market by Segment, U.S., 2019 – 2029
Chart 7‑2: Leading Competitors, Peripheral Vascular Stent Market, U.S., 2022
Chart 8‑1: PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029
Chart 8‑2: Leading Competitors, PTA Balloon Catheter Market, U.S., 2022
Chart 9‑1: Drug-Coated Balloon Market by Segment, U.S., 2019 – 2029
Chart 9‑2: Leading Competitors, Drug-Coated Balloon Market, U.S., 2022
Chart 10‑1: Atherectomy Device Market by Segment, U.S., 2019 – 2029
Chart 10‑2: Leading Competitors, Atherectomy Device Market, U.S., 2022
Chart 11‑1: Intravascular Lithotripsy Market by Care Setting, U.S., 2019 – 2029
Chart 12‑1: CTO Device Market by Segment, U.S., 2019 – 2029
Chart 12‑2: Leading Competitors, CTO Device Market, U.S., 2022
Chart 13‑1: Surgical Graft Market by Indication, U.S., 2019 – 2029
Chart 13‑2: Surgical Graft Market by Material, U.S., 2019 – 2029
Chart 13‑3: Leading Competitors, Surgical Graft Market, U.S., 2022
Chart 14‑1: Stent Graft Market by Segment, U.S., 2019 – 2029
Chart 14‑2: Leading Competitors, Stent Graft Market, U.S., 2022
Chart 15‑1: Embolic Protection Device Market by Segment, U.S., 2019 – 2029
Chart 15‑2: Leading Competitors, Embolic Protection Device Market, U.S., 2022
Chart 16‑1: Peripheral Thrombus Management Market Overview by Device Type, U.S., 2019 – 2029
Chart 16‑2: Peripheral Thrombus Management Market Overview by Indication, U.S., 2019 – 2029
Chart 16‑3: Leading Competitors, Peripheral Thrombus Management Market, U.S., 2022
Chart 17‑1: Inferior Vena Cava Filter & Retrieval Device Market by Segment, U.S., 2019 – 2029
Chart 17‑2: Leading Competitors, Inferior Vena Cava Filter & Retrieval Device Market, U.S., 2022
Chart 18‑1: Carotid Shunt Market, U.S., 2019 – 2029
Chart 18‑2: Leading Competitors, Carotid Shunt Market, U.S., 2022
Chart 19‑1: Transcarotid Artery Revascularization Market by Segment, U.S., 2019 – 2029
Chart 20‑1: Diagnostic & Interventional Catheter Market by Segment, U.S., 2019 – 2029
Chart 20‑2: Leading Competitors, Diagnostic & Interventional Catheter Market, U.S., 2022
Chart 21‑1: Diagnostic & Interventional Guidewire Market by Segment, U.S., 2019 – 2029
Chart 21‑2: Leading Competitors, Diagnostic & Interventional Guidewire Market, U.S., 2022
Chart 22‑1: Introducer Sheath Market by Segment, U.S., 2019 – 2029
Chart 22‑2: Leading Competitors, Introducer Sheath Market, U.S., 2022
Chart 23‑1: Vascular Closure Device Market by Device Type, U.S., 2019 – 2029
Chart 23‑2: Vascular Closure Device Market by Approach, U.S., 2019 – 2029
Chart 23‑3: Leading Competitors, Vascular Closure Device Market, U.S., 2022
Chart 24‑1: Transcatheter Embolization Device Market by Segment, U.S., 2019 – 2029
Chart 24‑2: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2022
Chart 25‑1: Peripheral IVUS Catheter Market, U.S., 2019 – 2029
Chart 25‑2: Leading Competitors, Peripheral IVUS Catheter Market, U.S., 2022

List of Figures

Figure 1‑1: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2022 (1 of 4)
Figure 1‑2: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2022 (2 of 4)
Figure 1‑3: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2022 (3 of 4)
Figure 1‑4: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2022 (4 of 4)
Figure 1‑5: Companies Researched in this Report (1 of 2)
Figure 1‑6: Companies Researched in this Report (2 of 2)
Figure 1‑7: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (1 of 4)
Figure 1‑8: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (2 of 4)
Figure 1‑9: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (3 of 4)
Figure 1‑10: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (4 of 4)
Figure 1‑11: Recent Events in the Peripheral Vascular Device Market, U.S., 2019 – 2022
Figure 1‑12: Peripheral Vascular Device Procedures Covered by Indication (1 of 3)
Figure 1‑13: Peripheral Vascular Device Procedures Covered by Indication (2 of 3)
Figure 1‑14: Peripheral Vascular Device Procedures Covered by Indication (3 of 3)
Figure 1‑15: Peripheral Vascular Device Procedures Covered by Device Type (1 of 5)
Figure 1‑16: Peripheral Vascular Device Procedures Covered by Device Type (2 of 5)
Figure 1‑17: Peripheral Vascular Device Procedures Covered by Device Type (3 of 5)
Figure 1‑18: Peripheral Vascular Device Procedures Covered by Device Type (4 of 5)
Figure 1‑19: Peripheral Vascular Device Procedures Covered by Device Type (5 of 5)
Figure 1‑20: Procedure Codes Investigated
Figure 1‑21: Peripheral Vascular Device Markets Covered (1 of 5)
Figure 1‑22: Peripheral Vascular Device Markets Covered (2 of 5)
Figure 1‑23: Peripheral Vascular Device Markets Covered (3 of 5)
Figure 1‑24: Peripheral Vascular Device Markets Covered (4 of 5)
Figure 1‑25: Peripheral Vascular Device Markets Covered (5 of 5)
Figure 1‑26: Key Report Updates
Figure 1‑27: Version History
Figure 2‑1: Peripheral Vascular Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 3)
Figure 2‑2: Peripheral Vascular Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 3)
Figure 2‑3: Peripheral Vascular Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (3 of 3)
Figure 2‑4: Peripheral Vascular Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 3)
Figure 2‑5: Peripheral Vascular Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 3)
Figure 2‑6: Peripheral Vascular Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (3 of 3)
Figure 2‑7: Peripheral Vascular Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 3)
Figure 2‑8: Peripheral Vascular Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 3)
Figure 2‑9: Peripheral Vascular Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (3 of 3)
Figure 4‑1: Peripheral Vascular Stent by Company (1 of 2)
Figure 4‑2: Peripheral Vascular Stent by Company (2 of 2)
Figure 4‑3: PTA Balloon Catheter by Company (1 of 3)
Figure 4‑4: PTA Balloon Catheter by Company (2 of 3)
Figure 4‑5: PTA Balloon Catheter by Company (3 of 3)
Figure 4‑6: Drug-Coated Balloon by Company
Figure 4‑7: Atherectomy Device by Company (1 of 2)
Figure 4‑8: Atherectomy Device by Company (2 of 2)
Figure 4‑9: Lithotripsy Device by Company
Figure 4‑10: Chronic Total Occlusion Device by Company
Figure 4‑11: Surgical Graft by Company (1 of 2)
Figure 4‑12: Surgical Graft by Company (2 of 2)
Figure 4‑13: Stent Graft by Company
Figure 4‑14: Embolic Protection Device by Company
Figure 4‑15: Peripheral Thrombus Management by Company
Figure 4‑16: Inferior Vena Cava Filter & Retrieval Device by Company (1 of 2)
Figure 4‑17: Inferior Vena Cava Filter & Retrieval Device by Company (2 of 2)
Figure 4‑18: Carotid Shunt by Company
Figure 4‑19: Transcarotid Artery Revascularization Device by Company
Figure 4‑20: Diagnostic and Interventional Catheters by Company (1 of 2)
Figure 4‑21: Diagnostic and Interventional Catheters by Company (2 of 2)
Figure 4‑22: Diagnostic and Interventional Guidewire by Company (1 of 3)
Figure 4‑23: Diagnostic and Interventional Guidewire by Company (2 of 3)
Figure 4‑24: Diagnostic and Interventional Guidewire by Company (3 of 3)
Figure 4‑25: Introducer Sheath by Company (1 of 2)
Figure 4‑26: Introducer Sheath by Company (2 of 2)
Figure 4‑27: Vascular Closure Device by Company
Figure 4‑28: Transcatheter Embolization Devices by Company (1 of 2)
Figure 4‑29: Transcatheter Embolization Devices by Company (2 of 2)
Figure 4‑30: Peripheral IVUS Catheter by Company
Figure 4‑31: Class 2 Device Recall VENOVO Venous Stent System
Figure 4‑32: Class 1 Device Recall VICI VENOUS STENT System
Figure 4‑33: Class 2 Device Recall ELUVIA
Figure 4‑34: Class 2 Device Recall PALMAZ GENESIS
Figure 4‑35: Class 2 Device Recall S.M.A.R.T. Flex
Figure 4‑36: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System
Figure 4‑37: Class 2 Device Recall Cordis S.M.A.R.T. CONTROL /S.M.A.R.T. Vascular Stent System
Figure 4‑38: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System
Figure 4‑39: Class 2 Device Recall Cordis Precise Nitinol Stent System
Figure 4‑40: Class 2 Device Recall Formula 418 Renal BalloonExpandable Stent
Figure 4‑41: Class 2 Device Recall Zilver 635 Biliary Stent
Figure 4‑42: Class 2 Device Recall Zilver 518 Biliary Stent
Figure 4‑43: Class 1 Device Recall Atrium
Figure 4‑44: Class 2 Device Recall Everflex Selfexpanding Peripheral Stent
Figure 4‑45: Class 2 Device Recall Medtronic Abre
Figure 4‑46: Class 2 Device Recall Medtronic Abre Venous Selfexpanding Sent System
Figure 4‑47: Class 2 Device Recall ENROUTE Transcarotid Stent System
Figure 4‑48: Class 2 Device Recall GORE VIABAHN VBX, BALLOON EXPANDABLE ENDOPROSTHESIS
Figure 4‑49: Class 2 Device Recall Conquest PTA Balloon Dilatation Catheter
Figure 4‑50: Class 2 Device Recall Conquest 40 PTA Dilatation Catheter
Figure 4‑51: Class 2 Device Recall Cordis SABER PTA Balloon Dilation Catheter
Figure 4‑52: Class 2 Device Recall Cordis POWERFLEX P3, PTA Dilation Catheter
Figure 4‑53: Class 2 Device Recall Cordis MAXI LD PTA Dilatation Catheter
Figure 4‑54: Class 2 Device Recall POWERFLEX PRO Percutaneous Transluminal Angioplasty (PTA) Catheter
Figure 4‑55: Class 1 Device Recall ADVANCE ENFORCER 35 FOCAL FORCE PTA BALLOON CATHETER
Figure 4‑56: Class 2 Device Recall Medtronic IN.PACT Admiral, Paclitaxelcoated PTA Balloon Catheter
Figure 4‑57: Class 2 Device Recall Chameleon PTA Balloon Dilation Catheter
Figure 4‑58: Class 2 Device Recall Boston Scientific ROTAPRO
Figure 4‑59: Class 2 Device Recall STEALTH 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
Figure 4‑60: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
Figure 4‑61: Class 1 Device Recall TurboHawk Plus
Figure 4‑62: Class 1 Device Recall HawkOne
Figure 4‑63: Class 2 Device Recall Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System
Figure 4‑64: Class 2 Device Recall Zurpaz(TM) MEDIUM CURL, ASYMMETRIC CURVE, Steerable Sheath
Figure 4‑65: Device Recall AngioJet Ultra 5000 A Console, Boston Scientific
Figure 4‑66: Class 1 Device Recall IntraClude IntraAortic Occlusion Device
Figure 4‑67: Class 2 Device Recall Intergard Woven Vascular Graft
Figure 4‑68: Class 2 Device Recall Interavascular SAS/Getinge
Figure 4‑69: Class 2 Device Recall Hemashield Gold Knitted Bifurcated
Figure 4‑70: Class 2 Device Recall Atrium ADVANTA VXT Vascular Graft
Figure 4‑71: Class 2 Device Recall HEMASHIELD MICROVEL Double Velour Knitted Vascular Grafts
Figure 4‑72: Class 2 Device Recall HEMASHIELD PLATINUM WOVEN/MICROVEL DOUBLE VELOUR VASCULAR GRAFTS
Figure 4‑73: Class 2 Device Recall HEMASHIELD PLATINUM Woven Double Velour Vascular Graft
Figure 4‑74: Class 2 Device Recall VASCUTEK/TERUMO
Figure 4‑75: Class 2 Device Recall Gore Propaten Vascular Graft
Figure 4‑76: Class 1 Device Recall ENDOLOGIX AFX2 Bifurcated Endograft System
Figure 4‑77: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Proximal (Aortic) Extension Endograft
Figure 4‑78: Class 1 Device Recall ENDOLOGIX AFX Endovascular AAA System
Figure 4‑79: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Limb (Iliac) Extension Endograft
Figure 4‑80: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
Figure 4‑81: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
Figure 4‑82: Class 2 Device Recall Zenith Alpha SpiralZ Endovascular Leg
Figure 4‑83: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
Figure 4‑84: Class 2 Device Recall Endurant, Endurant II and Endurant IIs Stent Graft Systems
Figure 4‑85: Class 2 Device Recall Endurant Stent Graft System
Figure 4‑86: Class 2 Device Recall Endurant II Stent Graft System
Figure 4‑87: Class 2 Device Recall Endurant II/IIs Stent Graft System
Figure 4‑88: Class 2 Device Recall Endurant II/IIs Stent Graft System
Figure 4‑89: Class 1 Device Recall Valiant Navion Thoracic Stent Graft System
Figure 4‑90: Class 2 Device Recall EKOS
Figure 4‑91: Class 2 Device Recall EkoSonic Endovascular Device
Figure 4‑92: Class 2 Device Recall EKOS Control System
Figure 4‑93: Class 2 Device Recall AngioJet Ultra Consoles Thrombectomy System
Figure 4‑94: Class 1 Device Recall ArrowTrerotola PTD
Figure 4‑95: Class 1 Device Recall ArrowTrerotola Percutaneous Thrombolytic Device
Figure 4‑96: Class 1 Device Recall ArrowTrerotola OverTheWire PTD Kit Percutaneous Thrombolytic Device: 7FR
Figure 4‑97: Class 3 Device Recall Cook
Figure 4‑98: Class 3 Device Recall Cook Celect Platinum Vena Cava Filter Set
Figure 4‑99: Class 2 Device Recall ENROUTE Transcarotid Stent System
Figure 4‑100: Class 2 Device Recall SoftVu Omni Flush Angiographic Catheter
Figure 4‑101: Class 2 Device Recall SEEKER(R) Crossing Support Catheter
Figure 4‑102: Class 1 Device Recall Imager II 5F Angiographic Catheter
Figure 4‑103: Class 1 Device Recall SUPER TORQUE MB 5F PIG
Figure 4‑104: Class 1 Device Recall CrossCath Support Catheter
Figure 4‑105: Class 2 Device Recall Torcon NB Advantage
Figure 4‑106: Class 2 Device Recall Amplatz extra Stiff Wire Guide
Figure 4‑107: Class 2 Device Recall Bentson Wire Guide
Figure 4‑108: Class 2 Device Recall Cope Mandril Wire Guide
Figure 4‑109: Class 2 Device Recall Cope Mandril Wire Guide (Nitinol)
Figure 4‑110: Class 2 Device Recall Coons Interventional Wire Guide
Figure 4‑111: Class 2 Device Recall Lunderquist Ring Torque Wire Guide
Figure 4‑112: Class 2 Device Recall Newton Wire Guide
Figure 4‑113: Class 2 Device Recall Roadrunner PC Hydrophilic Wire Guide
Figure 4‑114: Class 2 Device Recall Roadrunner PC Wire Guide (Nimble Floppy)
Figure 4‑115: Class 2 Device Recall Roadrunner PC Wire Guide (The Firm)
Figure 4‑116: Class 2 Device Recall Cook Roadrunner UniGlide Hydrophilic Wire Guide
Figure 4‑117: Class 2 Device Recall Cook Roadrunner PC Wire Guide
Figure 4‑118: Class 2 Device Recall Roadrunner Hydrophilic PC Wire Guide
Figure 4‑119: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER
Figure 4‑120: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER
Figure 4‑121: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS INTRODUCER
Figure 4‑122: Class 2 Device Recall Avanti Catheter Sheath Introducer
Figure 4‑123: Class 2 Device Recall
Figure 4‑124: Class 2 Device Recall Flexor CheckFlo Introducer
Figure 4‑125: Class 1 Device Recall Flexor CheckFlo Introducer
Figure 4‑126: Class 2 Device Recall Hilal Embolization Microcoil
Figure 4‑127: Class 2 Device Recall Nester Embolization Microcoil
Figure 4‑128: Class 2 Device Recall Tornado Embolization Microcoil
Figure 4‑129: Class 2 Device Recall Terumo AZUR Peripheral Coil System, Detachable 18
Figure 4‑130: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 35, CX Coil
Figure 4‑131: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 18, CX Coil
Figure 4‑132: Class 2 Device Recall OptiCross 35 15 MHz Peripheral Imaging Catheter
Figure 4‑133: Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion
Figure 4‑134: Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions (BELSTREAM)
Figure 4‑135: Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (XPEDITE)
Figure 4‑136: An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease (HEAL)
Figure 4‑137: SOLARIS Peripheral PMCF Trial
Figure 4‑138: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease
Figure 4‑139: Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access (RADIANCY)
Figure 4‑140: Stella Supera Siberia
Figure 4‑141: A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries (REGAL)
Figure 4‑142: Zilver® PTX® V Clinical Study
Figure 4‑143: In-Stent Restenosis Post-Approval Study
Figure 4‑144: BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR)
Figure 4‑145: VIVO Clinical Study
Figure 4‑146: ULTRASCORE™ Focused Force PTA Balloon Angioplasty for CLI Patients With Below the Knee Vessel Disease
Figure 4‑147: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon
Figure 4‑148: Ranger™ and Ranger™ SL (OTW) DCB in China
Figure 4‑149: The VaSecure BTK Study
Figure 4‑150: Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries (RANGER-SFA)
Figure 4‑151: A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon. (BIOPACT-RCT)
Figure 4‑152: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND)
Figure 4‑153: RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA)
Figure 4‑154: IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA
Figure 4‑155: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease
Figure 4‑156: ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (BTK PMS)
Figure 4‑157: IN.PACT Global Clinical Study
Figure 4‑158: ILLUMENATE Pivotal Post-Approval Study (PAS)
Figure 4‑159: BIOLUX P-III BENELUX All-Comers Registry
Figure 4‑160: Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (SAFE-DCB)
Figure 4‑161: Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy (KAIZEN)
Figure 4‑162: Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA
Figure 4‑163: Revascularization of Total or Sub-total Occluded Peripheral Arteries With ByCross® Device. Post Market Clinical Follow-up
Figure 4‑164: Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease (PATHFINDER-I)
Figure 4‑165: JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon
Figure 4‑166: Pantheris Atherectomy Treatment of In-Stent Restenosis in Lower Extremity Arteries (INSIGHT)
Figure 4‑167: Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for PAD Treatment
Figure 4‑168: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II)
Figure 4‑169: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY)
Figure 4‑170: Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System
Figure 4‑171: SOLUTION Trial in China
Figure 4‑172: Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System (Disrupt PAD+)
Figure 4‑173: Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Figure 4‑174: A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches (PANTHER)
Figure 4‑175: Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access
Figure 4‑176: Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
Figure 4‑177: Post-Approval Study of the TREO Abdominal Stent-Graft System (TREO PAS)
Figure 4‑178: The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease
Figure 4‑179: Zenith Alpha™ Abdominal Endovascular Graft
Figure 4‑180: Fenestrated AAA Endovascular Graft Post-Approval Study
Figure 4‑181: transShield Embolic Protection System Feasibility Study
Figure 4‑182: Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Figure 4‑183: Preservation of Venous Valvular Function After PMT for Acute DVT (PREFER)
Figure 4‑184: A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo Aspiration System (STRIDE)
Figure 4‑185: FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH)
Figure 4‑186: JETi Peripheral Thrombectomy Registry (JETi)
Figure 4‑187: Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever
Figure 4‑188: Forceps vs. Snare IVC Filter Removal
Figure 4‑189: Predictors of Attempted Inferior Vena Cava Filters Retrieval
Figure 4‑190: Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter
Figure 4‑191: Cook IVC Filter Study (CIVC)
Figure 4‑192: Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE)
Figure 4‑193: Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease
Figure 4‑194: The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Evaluation (DW-MRI-US)
Figure 4‑195: The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Study (DW-MRI OUS)
Figure 4‑196: Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression (ReliaSeal)
Figure 4‑197: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial
Figure 4‑198: Vascular Closure Device in Transcatheter Aortic Valve Replacement
Figure 4‑199: Manta™ Versus Suture-based Closure After Transcatheter Aortic Valve Implantation Trial (MASH-TAVI)
Figure 4‑200: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)
Figure 4‑201: (HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds
Figure 4‑202: Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)
Figure 4‑203: Use of Interlocking Detachable Coils System in Embolization of Peripheral Arterial Embolization
Figure 4‑204: CATERPILLAR™ Arterial Embolization Device Study (CHRYSALIS)
Figure 4‑205: LC Bead LUMI for Prostatic Artery Embolization
Figure 5‑1: Peripheral Vascular Device Market by Segment, U.S., 2019 – 2029 (US$M) (1 of 3)
Figure 5‑2: Peripheral Vascular Device Market by Segment, U.S., 2019 – 2029 (US$M) (2 of 3)
Figure 5‑3: Peripheral Vascular Device Market by Segment, U.S., 2019 – 2029 (US$M) (3 of 3)
Figure 5‑4: Leading Competitors, Peripheral Vascular Device Market, U.S., 2022 (1 of 4)
Figure 5‑5: Leading Competitors, Peripheral Vascular Device Market, U.S., 2022 (2 of 4)
Figure 5‑6: Leading Competitors, Peripheral Vascular Device Market, U.S., 2022 (3 of 4)
Figure 5‑7: Leading Competitors, Peripheral Vascular Device Market, U.S., 2022 (4 of 4)
Figure 5‑8: SWOT Analysis, Abbott (1 of 2)
Figure 5‑9: SWOT Analysis, Abbott (2 of 2)
Figure 5‑10: SWOT Analysis, Becton Dickinson (1 of 2)
Figure 5‑11: SWOT Analysis, Becton Dickinson (2 of 2)
Figure 5‑12: SWOT Analysis, Boston Scientific
Figure 5‑13: SWOT Analysis, Cardinal Health
Figure 5‑14: SWOT Analysis, Cardiovascular Systems, Inc.
Figure 5‑15: SWOT Analysis, Cook Medical
Figure 5‑16: SWOT Analysis, Medtronic
Figure 5‑17: SWOT Analysis, Penumbra
Figure 5‑18: SWOT Analysis, Philips
Figure 5‑19: SWOT Analysis, Shockwave Medical
Figure 5‑20: SWOT Analysis, Silk Road Medical
Figure 5‑21: SWOT Analysis, Terumo (1 of 2)
Figure 5‑22: SWOT Analysis, Terumo (2 of 2)
Figure 5‑23: SWOT Analysis, W.L. Gore
Figure 6‑1: Procedure Codes Investigated, U.S., 2022
Figure 6‑2: Peripheral Vascular Procedures by Segment, U.S., 2019 – 2029 (1 of 3)
Figure 6‑3: Peripheral Vascular Procedures by Segment, U.S., 2019 – 2029 (2 of 3)
Figure 6‑4: Peripheral Vascular Procedures by Segment, U.S., 2019 – 2029 (3 of 3)
Figure 6‑5: Above-the-Knee Procedures by Segment, U.S., 2019 – 2029 (1 of 2)
Figure 6‑6: Above-the-Knee Procedures by Segment, U.S., 2019 – 2029 (2 of 2)
Figure 6‑7: Above-the-Knee Stent Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑8: Above-the-Knee Stent Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑9: Above-the-Knee POBA Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑10: Above-the-Knee DCB Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑11: Intravascular Lithotripsy Procedures, U.S., 2019 – 2029
Figure 6‑12: Above-the-Knee Atherectomy without Stent Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑13: Above-the-Knee Atherectomy with Stent Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑14: Surgical Graft Procedures, U.S., 2019 – 2029
Figure 6‑15: Below-the-Knee Procedures by Intervention Type, U.S., 2019 – 2029 (1 of 2)
Figure 6‑16: Below-the-Knee Procedures by Intervention Type, U.S., 2019 – 2029 (2 of 2)
Figure 6‑17: Below-the-Knee Stent Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑18: Below-the-Knee Stent Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑19: Below-the-Knee POBA Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑20: Below-the-Knee DCB Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑21: Intravascular Lithotripsy Procedures, U.S., 2019 – 2029
Figure 6‑22: Below-the-Knee Atherectomy without Stent Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑23: Below-the-Knee Atherectomy with Stent Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑24: Surgical Graft Procedures, U.S., 2019 – 2029
Figure 6‑25: Iliac Procedures by Intervention Type, U.S., 2019 – 2029
Figure 6‑26: Iliac Stent Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑27: Iliac Stent Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑28: Iliac POBA Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑29: AV Access Procedures by Intervention Type, U.S., 2019 – 2029
Figure 6‑30: AV Access Covered Stent Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑31: AV Access POBA Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑32: AV Access DCB Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑33: Renal Procedures by Intervention Type, U.S., 2019 – 2029
Figure 6‑34: Carotid Intervention by Procedure Type, U.S., 2019 – 2029
Figure 6‑35: Peripheral Vascular Stent Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑36: Peripheral Arterial Stent Procedures by Stent Type, U.S., 2019 – 2029
Figure 6‑37: Bare-Metal Stent Procedures by Indication, U.S., 2019 – 2029
Figure 6‑38: Bare-Metal Iliac Stent Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑39: Bare-Metal Fem-Popliteal Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑40: Bare-Metal Infra-Popliteal Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑41: Bare-Metal Stent Procedures by Delivery Method, U.S., 2019 – 2029
Figure 6‑42: Covered Stent Procedures by Indication, U.S., 2019 – 2029
Figure 6‑43: Drug-Eluting Stent Procedures by Indication, U.S., 2019 – 2029
Figure 6‑44: Peripheral Venous Stent, U.S., 2019 – 2029
Figure 6‑45: PTA Balloon Catheter Procedures by Segment, U.S., 2019 – 2029
Figure 6‑46: Drug-Coated Balloon Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑47: Drug-Coated Balloon Procedures by Indication, U.S., 2019 – 2029
Figure 6‑48: Atherectomy Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑49: Atherectomy Procedures by Indication, U.S., 2019 – 2029 (1 of 2)
Figure 6‑50: Atherectomy Procedures by Indication, U.S., 2019 – 2029 (2 of 2)
Figure 6‑51: Fem-Popliteal Artery Atherectomy Procedures by Type, U.S., 2019 – 2029
Figure 6‑52: Infra-Popliteal Artery Atherectomy Procedures by Type, U.S., 2019 – 2029
Figure 6‑53: Atherectomy Procedures by Care Setting, U.S., 2019 – 2029
Figure 6‑54: Intravascular Lithotripsy Procedures by Indication, U.S., 2019 – 2029
Figure 6‑55: CTO Device Procedures by Type, U.S., 2019 – 2029
Figure 6‑56: Surgical Graft Procedures by Graft Material, U.S., 2019 – 2029
Figure 6‑57: Surgical Graft Procedures by Indication, U.S., 2019 – 2029
Figure 6‑58: Lower Limb Surgical Graft Procedures by Anatomy, U.S., 2019 – 2029
Figure 6‑59: Aorta Repair Surgical Graft Procedures by Anatomy, U.S., 2019 – 2029
Figure 6‑60: Endovascular Stent Graft Procedures by Type, U.S., 2019 – 2029
Figure 6‑61: EVAR Procedures by Anatomy, U.S., 2019 – 2029
Figure 6‑62: EVAR Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑63: EVAR Procedures by Complexity, U.S., 2019 – 2029
Figure 6‑64: EVAR Procedures by Fenestration, U.S., 2019 – 2029
Figure 6‑65: EVAR Procedures by Anesthesia Type, U.S., 2019 – 2029
Figure 6‑66: EVAR Procedures by Gender, U.S., 2019 – 2029
Figure 6‑67: TEVAR Procedures by Indication, U.S., 2019 – 2029
Figure 6‑68: TEVAR Procedures by Anesthesia Type, U.S., 2019 – 2029
Figure 6‑69: TEVAR Procedures by Gender, U.S., 2019 – 2029
Figure 6‑70: Embolic Protection Procedures by Type, U.S., 2019 – 2029
Figure 6‑71: Peripheral Thrombus Management Procedures by Procedure Type, U.S., 2019 – 2029
Figure 6‑72: Peripheral Thrombus Management Procedures by Indication, U.S., 2019 – 2029
Figure 6‑73: Inferior Vena Cava Filter Procedures by Procedure Type, U.S., 2019 – 2029
Figure 6‑74: IVCF Placement Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑75: Carotid Intervention Procedures by Procedure Type, U.S., 2019 – 2029
Figure 6‑76: Vascular Closure Device Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑77: Invasive Vascular Closure Procedures by Device Size, U.S., 2019 – 2029
Figure 6‑78: Vascular Closure Procedures by Approach, U.S., 2019 – 2029
Figure 6‑79: Transcatheter Embolization Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑80: Transcatheter Particle Embolization Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑81: Transcatheter Coil Embolization Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑82: Peripheral IVUS Procedures by Indication, U.S., 2019 – 2029
Figure 6‑83: Peripheral IVUS Procedures by Care Setting, U.S., 2019 – 2029
Figure 7‑1: Peripheral Vascular Stent Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 7‑2: Peripheral Arterial Stent Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 7‑3: Total Peripheral Arterial Stent Market, U.S., 2019 – 2029
Figure 7‑4: Total Bare-Metal Peripheral Arterial Stent Market, U.S., 2019 – 2029
Figure 7‑5: Bare-Metal Peripheral Arterial Stent Market by Indication, U.S., 2019 – 2029
Figure 7‑6: Bare-Metal Carotid Stent Market, U.S., 2019 – 2029
Figure 7‑7: Bare-Metal Iliac Stent Market, U.S., 2019 – 2029
Figure 7‑8: Bare-Metal Renal Stent Market, U.S., 2019 – 2029
Figure 7‑9: Bare-Metal Fem-Popliteal Stent Market, U.S., 2019 – 2029
Figure 7‑10: Bare-Metal Infra-Popliteal Stent Market, U.S., 2019 – 2029
Figure 7‑11: Bare-Metal Stent Market by Delivery Platform, U.S., 2019 – 2029
Figure 7‑12: Self-Expanding Bare-Metal Stent Market, U.S., 2019 – 2029
Figure 7‑13: Balloon Expanding Bare-Metal Stent Market, U.S., 2019 – 2029
Figure 7‑14: Covered Stent Market by Segment, U.S., 2019 – 2029
Figure 7‑15: Total Covered Stent Market, U.S., 2019 – 2029
Figure 7‑16: Iliac Covered Stent Market, U.S., 2019 – 2029
Figure 7‑17: Fem-Popliteal Covered Stent Market, U.S., 2019 – 2029
Figure 7‑18: AV Access Covered Stent Market, U.S., 2019 – 2029
Figure 7‑19: Drug-Eluting Stent Market by Segment, U.S., 2019 – 2029
Figure 7‑20: Total Drug-Eluting Stent Market, U.S., 2019 – 2029
Figure 7‑21: SFA Drug-Eluting Stent Market, U.S., 2019 – 2029
Figure 7‑22: Infra-Popliteal Drug-Eluting Stent Market, U.S., 2019 – 2029
Figure 7‑23: Venous Stent Market, U.S., 2019 – 2029
Figure 7‑24: Units Sold by Stent Length, Bare-Metal Carotid Stent Market, U.S., 2019 – 2029
Figure 7‑25: Units Sold by Stent Length, Bare-Metal Renal Stent Market, U.S., 2019 – 2029
Figure 7‑26: Units Sold by Stent Length, Bare-Metal Iliac Stent Market, U.S., 2019 – 2029
Figure 7‑27: Units Sold by Stent Length, Bare-Metal Fem-Popliteal Stent Market, U.S.,  2019 – 2029
Figure 7‑28: Leading Competitors, Peripheral Vascular Stent Market, U.S., 2022
Figure 7‑29: Leading Competitors, Bare-Metal Arterial Peripheral Vascular Stent Market, U.S., 2022
Figure 7‑30: Leading Competitors, Drug-Eluting Peripheral Vascular Stent Market, U.S., 2022
Figure 8‑1: PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 8‑2: Total PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑3: Standard PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 8‑4: Total Standard PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑5: Hospital Standard PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑6: Office-Based Lab Standard PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑7: High-Pressure PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 8‑8: Total High-Pressure PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑9: Hospital High-Pressure PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑10: Office-Based Lab High-Pressure PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑11: Large PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 8‑12: Total Large PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑13: Hospital Large PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑14: Office-Based Lab Large PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑15: Total Small PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑16: 0.014” Small PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑17: 0.018” Small PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑18: Hospital Small PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑19: Office-Based Lab Small PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑20: Specialty PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 8‑21: Total Specialty PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑22: Hospital Specialty PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑23: Office-Based Lab Specialty PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑24: Units Sold by Application, PTA Balloon Catheter Market, U.S., 2019 – 2029
Figure 8‑25: Leading Competitors, PTA Balloon Catheter Market, U.S., 2022
Figure 9‑1: Drug-Coated Balloon Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 9‑2: Total Drug-Coated Balloon Market, U.S., 2019 – 2029
Figure 9‑3: SFA DCB Market, U.S., 2019 – 2029
Figure 9‑4: BTK DCB Market, U.S., 2019 – 2029
Figure 9‑5: AV Access DCB Market, U.S., 2019 – 2029
Figure 9‑6: Units Sold by Care Setting, Drug-Coated Balloon Market, U.S., 2019 – 2029
Figure 9‑7: Leading Competitors, Drug-Coated Balloon Market, U.S., 2022
Figure 10‑1: Atherectomy Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 10‑2: Total Laser Atherectomy Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 10‑3: Laser Atherectomy Disposable Market, U.S., 2019 – 2029
Figure 10‑4: Laser Atherectomy Console Market, U.S., 2019 – 2029 (1 of 2)
Figure 10‑5: Laser Atherectomy Console Market, U.S., 2019 – 2029 (2 of 2)
Figure 10‑6: Mechanical Atherectomy Disposable Market, U.S., 2019 – 2029
Figure 10‑7: Atherectomy Disposable Market by Care Setting, U.S., 2019 – 2029 (US$M)
Figure 10‑8: Hospital Atherectomy Disposable Market, U.S., 2019 – 2029
Figure 10‑9: Office-Based Lab Atherectomy Disposable Market, U.S., 2019 – 2029
Figure 10‑10: Leading Competitors, Atherectomy Device Market, U.S., 2022
Figure 11‑1: Intravascular Lithotripsy Market by Care Setting, U.S., 2019 – 2029 (US$M)
Figure 11‑2: Hospital Intravascular Lithotripsy Market, U.S., 2019 – 2029
Figure 11‑3: Office-Based Lab Intravascular Lithotripsy Market, U.S., 2019 – 2029
Figure 11‑4: Leading Competitors, Intravascular Lithotripsy Market, U.S., 2022
Figure 12‑1: CTO Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 12‑2: Total CTO Device Market, U.S., 2019 – 2029
Figure 12‑3: Re-Entry Device Market, U.S., 2019 – 2029
Figure 12‑4: Re-Canalization Device Market, U.S., 2019 – 2029
Figure 12‑5: Leading Competitors, CTO Device Market, U.S., 2022
Figure 13‑1: Surgical Graft Market by Indication, U.S., 2019 – 2029 (US$M)
Figure 13‑2: Surgical Graft Market by Material, U.S., 2019 – 2029 (US$M)
Figure 13‑3: Total Surgical Graft Market, U.S., 2019 – 2029
Figure 13‑4: Lower Limb Surgical Graft Market, U.S., 2019 – 2029 (US$M)
Figure 13‑5: Total Lower Limb Surgical Graft Market, U.S., 2019 – 2029
Figure 13‑6: Above-the-Knee Surgical Graft Market, U.S., 2019 – 2029
Figure 13‑7: Below-the-Knee Surgical Graft Market, U.S., 2019 – 2029
Figure 13‑8: Aorta Repair Surgical Graft Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 13‑9: Total Aorta Repair Surgical Graft Market, U.S., 2019 – 2029
Figure 13‑10: Abdominal Aortic Aneurysm Surgical Graft Market, U.S., 2019 – 2029
Figure 13‑11: Thoracic Aortic Aneurysm Surgical Graft Market, U.S., 2019 – 2029
Figure 13‑12: Extra-Anatomical Bypass Surgical Graft Market, U.S., 2019 – 2029
Figure 13‑13: Polyester Surgical Graft Market, U.S., 2019 – 2029
Figure 13‑14: ePTFE Surgical Graft Market, U.S., 2019 – 2029
Figure 13‑15: Leading Competitors, Surgical Graft Market, U.S., 2022
Figure 14‑1: Stent Graft Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 14‑2: Total Stent Graft Market, U.S., 2019 – 2029
Figure 14‑3: AAA Stent Graft Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 14‑4: Total AAA Stent Graft Market, U.S., 2019 – 2029
Figure 14‑5: Bifurcated Main Body Graft Market, U.S., 2019 – 2029
Figure 14‑6: Contralateral/Ipsilateral Iliac Leg/Limb Market, U.S., 2019 – 2029
Figure 14‑7: Aorto-uni-iliac (AUI) Stent Graft Market, U.S., 2019 – 2029
Figure 14‑8: Iliac Extension Market, U.S., 2019 – 2029
Figure 14‑9: Aortic Extension Market, U.S., 2019 – 2029
Figure 14‑10: FAA Stent Graft Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 14‑11: Total FAA Stent Graft Market, U.S., 2019 – 2029
Figure 14‑12: Fenestrated Distal Bifurcated Graft Market, U.S., 2019 – 2029
Figure 14‑13: Fenestrated Proximal Body Graft Market, U.S., 2019 – 2029
Figure 14‑14: TAA Stent Graft Market, U.S., 2019 – 2029
Figure 14‑15: Leading Competitors, Stent Graft Market, U.S., 2022
Figure 14‑16: Leading Competitors, AAA Stent Graft Market, U.S., 2022
Figure 15‑1: Embolic Protection Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 15‑2: Total Embolic Protection Device Market, U.S., 2019 – 2029
Figure 15‑3: Carotid EPD Market, U.S., 2019 – 2029
Figure 15‑4: Alternative EPD Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 15‑5: Total Alternative EPD Market, U.S., 2019 – 2029
Figure 15‑6: Renal EPD Market, U.S., 2019 – 2029
Figure 15‑7: Lower Limb EPD Market, U.S., 2019 – 2029
Figure 15‑8: Leading Competitors, Embolic Protection Device Market, U.S., 2022
Figure 16‑1: Peripheral Thrombus Management Market Overview by Device Type, U.S., 2019 – 2029 (US$M)
Figure 16‑2: Peripheral Thrombus Management Market Overview by Indication, U.S., 2019 – 2029 (US$M)
Figure 16‑3: Total Peripheral Thrombus Management Market, U.S., 2019 – 2029
Figure 16‑4: Traditional Thrombectomy Market, U.S., 2019 – 2029
Figure 16‑5: Pharmacomechanical Thrombectomy Market, U.S., 2019 – 2029
Figure 16‑6: Catheter Directed Thrombolysis Market, U.S., 2019 – 2029
Figure 16‑7: AV Access Thrombectomy Device Market, U.S., 2019 – 2029
Figure 16‑8: Arterial Thrombectomy Device Market, U.S., 2019 – 2029
Figure 16‑9: Venous Thrombectomy Device Market, U.S., 2019 – 2029
Figure 16‑10: Leading Competitors, Peripheral Thrombus Management Market, U.S., 2022
Figure 17‑1: Inferior Vena Cava Filter & Retrieval Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 17‑2: Retrievable IVCF Market, U.S., 2019 – 2029
Figure 17‑3: Permanent IVCF Market, U.S., 2019 – 2029
Figure 17‑4: IVCF Retrieval Device Market, U.S., 2019 – 2029
Figure 17‑5: Leading Competitors, Inferior Vena Cava Filter & Retrieval Device Market, U.S., 2022
Figure 18‑1: Carotid Shunt Market, U.S., 2019 – 2029
Figure 18‑2: Leading Competitors, Carotid Shunt Market, U.S., 2022
Figure 19‑1: Transcarotid Artery Revascularization Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 19‑2: Transcarotid Bare-Metal Stent Market, U.S., 2019 – 2029
Figure 19‑3: TCAR Neuroprotection System Market, U.S., 2019 – 2029
Figure 19‑4: Leading Competitors, Transcarotid Artery Revascularization Market, U.S., 2022
Figure 20‑1: Diagnostic & Interventional Catheter Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 20‑2: Total Diagnostic & Interventional Catheter Market, U.S., 2019 – 2029
Figure 20‑3: Diagnostic Catheter Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 20‑4: Total Diagnostic Catheter Market, U.S., 2019 – 2029
Figure 20‑5: Standard Diagnostic Catheter Market, U.S., 2019 – 2029
Figure 20‑6: Hydrophilic Diagnostic Catheter Market, U.S., 2019 – 2029
Figure 20‑7: Support Catheter Market, U.S., 2019 – 2029
Figure 20‑8: Leading Competitors, Diagnostic & Interventional Catheter Market, U.S., 2022
Figure 21‑1: Diagnostic & Interventional Guidewire Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 21‑2: Total Diagnostic & Interventional Guidewire Market, U.S., 2019 – 2029
Figure 21‑3: Standard Guidewire Market, U.S., 2019 – 2029
Figure 21‑4: Hydrophilic Guidewire Market, U.S., 2019 – 2029
Figure 21‑5: Leading Competitors, Diagnostic & Interventional Guidewire Market, U.S., 2022
Figure 22‑1: Introducer Sheath Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 22‑2: Total Introducer Sheath Market, U.S., 2019 – 2029
Figure 22‑3: Standard Introducer Sheath Market, U.S., 2019 – 2029
Figure 22‑4: Guiding Introducer Sheath Market, U.S., 2019 – 2029
Figure 22‑5: Leading Competitors, Introducer Sheath Market, U.S., 2022
Figure 23‑1: Vascular Closure Device Market by Device Type, U.S., 2019 – 2029 (US$M)
Figure 23‑2: Vascular Closure Device Market by Approach, U.S., 2019 – 2029 (US$M)
Figure 23‑3: Total Vascular Closure Device Market, U.S., 2019 – 2029
Figure 23‑4: Non-Invasive VCD Market, U.S., 2019 – 2029
Figure 23‑5: Invasive Vascular Closure Device Market by Application, U.S., 2019 – 2029 (US$M)
Figure 23‑6: Total Invasive Vascular Closure Device Market, U.S., 2019 – 2029
Figure 23‑7: Small-Bore Invasive VCD Market, U.S., 2019 – 2029
Figure 23‑8: Large-Bore Invasive VCD Market, U.S., 2019 – 2029
Figure 23‑9: Radial VCD Market, U.S., 2019 – 2029
Figure 23‑10: Femoral VCD Market, U.S., 2019 – 2029
Figure 23‑11: Leading Competitors by Device Type, Vascular Closure Device Market, U.S., 2022
Figure 23‑12: Leading Competitors, Invasive Vascular Closure Device Market, U.S., 2022
Figure 23‑13: Leading Competitors by Approach, Vascular Closure Device Market, U.S., 2022
Figure 24‑1: Transcatheter Embolization Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 24‑2: Total Transcatheter Embolization Device Market, U.S., 2019 – 2029
Figure 24‑3: Embolization Particle Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 24‑4: Total Embolization Particle Market, U.S., 2019 – 2029
Figure 24‑5: PVA Embolization Particle Market, U.S., 2019 – 2029
Figure 24‑6: Microsphere Embolization Particle Market, U.S., 2019 – 2029
Figure 24‑7: Drug-Eluting Embolization Particle Market, U.S., 2019 – 2029
Figure 24‑8: Radioactive Embolization Particle Market, U.S., 2019 – 2029
Figure 24‑9: Embolization Coil Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 24‑10: Total Embolization Coil Market, U.S., 2019 – 2029
Figure 24‑11: Pushable Coil Market, U.S., 2019 – 2029
Figure 24‑12: Detachable Coil Market, U.S., 2019 – 2029
Figure 24‑13: Embolization Liquid Market, U.S., 2019 – 2029
Figure 24‑14: Embolization Plug Market, U.S., 2019 – 2029
Figure 24‑15: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2022
Figure 24‑16: Leading Competitors, Embolization Particle Market, U.S., 2022
Figure 24‑17: Leading Competitors, Embolization Coil Market, U.S., 2022
Figure 25‑1: Peripheral IVUS Catheter Market, U.S., 2019 – 2029
Figure 25‑2: Leading Competitors, Peripheral IVUS Catheter Market, U.S., 2022

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

The full report suite on the U.S. market for peripheral vascular devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management devices, inferior vena cava filters (IVCFs) and retrieval devices, carotid shunts, transcarotid arterial revascularization (TCAR) flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral IVUS catheters.

  • 2023
  • 10 Years
  • United States
  • 2023-02-14
  • 756
  • MedSuite
SKU: iDATA_USPV23_MS Categories: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library